Las Vegas, NV -- (SBWIRE) -- 03/21/2013 -- AMARANTUS BIOSCI INC (OTC:AMBS) has appointed Mark Benedyk, Ph.D., who is currently a Managing partner at Rila Partners LLC, a business and corporate consultancy, to its Board of Directors. Dr. Benedyk has worked for Amarantus BioScience, Inc. as a Corporate Advisor since 2011 and has more than 18 years of experience as a senior business development executive and consultant to life science companies.
Dr. Benedyk is enthusiastic about joining the board as the Company is at its primary level of scientific and business development growth, and is eager to help the Company with its advancement towards the Parkinson’s disease.
Besides the new addition to the board, Amarantus BioScience Inc has announced that its shares no longer are to be traded on Berlin-Bremen Stock Exchange BBSE, as BBSE is one of the few exchanges which allows the listing and trading of shares without the consent of the listed companies itself.
The Company did not authorize BBSE for the listing of its stock, and demanded cessation of its unauthorized trading. BBSE, in accordance to the demand has ceased trading of its common stock.
To find out what OTCMAGIC projects for Amarantus BioScience Inc for both short term and long term please click here: AMBS
OTCMAGIC Spends all day scouring the markets for the next huge Penny Stock Winner. Investors have come to trust us for our up to date commentary on all hot stocks so please visit OTCMAGIC right now and see what it’s all about for yourself! At 30,000 Visitors a Month and growing rapidly OTCMAGIC is the hottest thing in Penny Stocks!
Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. PLEASE NOTE: OTCMagic.com employees are not registered as an Investment Advisor in any jurisdiction whatsoever. Full disclaimer can be read at http://OTCMagic.com/disclaimer. Release of Liability: Through use of this website viewing or using you agree to hold OTCMagic.com, its operators owners and employees harmless and to completely release them from any and all liability due to any and all loss monetary or otherwise, damage monetary or otherwise, or injury (monetary or otherwise) that you may incur. The information contained herein is based on sources which we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. OTCMagic.com affiliates may from time to time have a position in the securities mentioned herein and may increase or decrease such positions without notice. Any opinions expressed are subject to change without notice. OTCMagic.com encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and OTCMagic.com. We make no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled companies. This is not a solicitation to buy or sell any securities. Any claims or Statements should be deemed hypothetical. OTCMagic.com, nor any of its affiliates are not registered investment advisors or broker dealers.
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-321-1250 (International)